On the Postdoc Plantation

On the Postdoc Plantation Scientists should set up some system of assurances that funded scientists must behave as ethical employers. The practice that a 60- to 100-hour work week is required or an employee will be fired while being paid for 40 hours a week is an unfair labor practice. If an employer in the private sector paid 40 hours of wages to someone forced to work 80 hours, s/he would be considered a criminal. Yet this practice goes unnoticed in science every day. Ethical scientists

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Scientists should set up some system of assurances that funded scientists must behave as ethical employers. The practice that a 60- to 100-hour work week is required or an employee will be fired while being paid for 40 hours a week is an unfair labor practice. If an employer in the private sector paid 40 hours of wages to someone forced to work 80 hours, s/he would be considered a criminal. Yet this practice goes unnoticed in science every day.

Ethical scientists on university faculties cannot compete against huge teams of scientists that generate preliminary results over the whip-scarred backs of their postdocs. These PIs with large teams of postdocs have plenty of National Institutes of Health funding, and the PI may create more problems for society than they solve for science.

Unfortunately, the unethical scientists are not likely to have read beyond the title of your story1 or given ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies